Physician
Plateau Pediatrics, PLC
Plateau Pediatrics, PLC was paid $10.63M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoPLATEAU PEDIATRICS, PLC
CROSSVILLE, TN 38555
CROSSVILLE, TN 38555
33aNPI1043285729assigned 02/17/2006
33bProvider typePediatrics Physician
28Total paid$10.63M
24GClaims456,731
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#10 of 333
Median peer was paid$139K
This provider vs. median76×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,741 | $1.03M | |
| 2019 | 56,979 | $1.30M | |
| 2020 | 66,451 | $1.37M | |
| 2021 | 68,759 | $1.67M | |
| 2022 | 74,803 | $1.81M | |
| 2023 | 69,417 | $1.72M | |
| 2024incomplete | 74,581 | $1.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 68,156 | 59,297 | $3.05M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 52,743 | 24,144 | $1.34M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 14,563 | 12,070 | $1.02M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.9% | 12,647 | 10,693 | $836K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.9% | 11,688 | 9,816 | $730K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 10,060 | 8,312 | $707K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 6.1% | 25,791 | 21,294 | $650K |
| 96160 | 6.0% | 36,841 | 28,796 | $635K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 4,569 | 3,620 | $353K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 8,620 | 7,568 | $249K |
| 96161 | 1.1% | 7,804 | 6,632 | $116K | |
| 96127 | <1% | 23,744 | 18,585 | $102K |
77 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,182 | $87K |
| 92551 | <1% | 10,635 | $84K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 8,623 | $59K |
| 99401 | <1% | 2,955 | $58K | |
| 54150 | <1% | 351 | $54K | |
| 99051 | <1% | 9,227 | $41K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,301 | $34K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,221 | $32K |
| 99460 | <1% | 635 | $31K | |
| 83655 | <1% | 2,640 | $31K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 586 | $29K |
| 3008F | <1% | 26,100 | $26K | |
| 99463 | <1% | 408 | $26K | |
| 99050 | <1% | 1,131 | $22K | |
| 92558 | <1% | 2,350 | $16K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 486 | $15K |
| 99177 | <1% | 2,432 | $14K | |
| 90670 | <1% | 7,323 | $14K | |
| 87807 | <1% | 1,389 | $14K | |
| 90461 | <1% | 17,778 | $13K | |
| 96158 | <1% | 545 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,396 | $11K |
| 36416 | <1% | 8,218 | $11K | |
| 99173 | <1% | 2,242 | $9K | |
| 90698 | <1% | 8,813 | $8K | |
| 90651 | <1% | 653 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 251 | $6K |
| 85018 | <1% | 2,616 | $6K | |
| 90686 | <1% | 10,026 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 439 | $5K |
| 81003 | <1% | 2,271 | $4K | |
| 90680 | <1% | 5,107 | $4K | |
| 90677 | <1% | 1,462 | $4K | |
| 88720 | <1% | 890 | $4K | |
| 0001A | <1% | 96 | $3K | |
| 0002A | <1% | 92 | $3K | |
| 99383 | <1% | 53 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 39 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 85 | $3K |
| 90716 | <1% | 521 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 179 | $3K |
| 3078F | <1% | 513 | $2K | |
| 3074F | <1% | 511 | $2K | |
| 90734 | <1% | 409 | $2K | |
| 80061 | Lipid panel | <1% | 152 | $2K |
| 0031A | <1% | 67 | $2K | |
| 99384 | <1% | 18 | $2K | |
| 90707 | <1% | 523 | $2K | |
| 90633 | <1% | 2,235 | $2K | |
| 88738 | <1% | 361 | $2K | |
| 96159 | <1% | 125 | $1K | |
| 96380 | <1% | 58 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $927.91 |
| 0072A | <1% | 23 | $817.76 | |
| 90710 | <1% | 90 | $787.11 | |
| 0071A | <1% | 23 | $760.01 | |
| 90619 | <1% | 73 | $701.06 | |
| 90672 | <1% | 632 | $630.33 | |
| 90744 | <1% | 2,824 | $623.25 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 16 | $526.92 |
| 90656 | <1% | 592 | $377.67 | |
| 90696 | <1% | 76 | $181.65 | |
| 90715 | <1% | 98 | $157.77 | |
| 90660 | <1% | 85 | $98.70 | |
| 82272 | <1% | 34 | $91.12 | |
| 82962 | <1% | 19 | $58.30 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 91 | $49.36 |
| 90674 | <1% | 499 | $28.44 | |
| 90685 | <1% | 459 | $24.78 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 75 | $9.60 |
| 99072 | <1% | 4,281 | $4.99 | |
| 91300 | <1% | 311 | $0.45 | |
| 91307 | <1% | 133 | $0.30 | |
| 91303 | <1% | 65 | $0.12 | |
| 90381 | <1% | 17 | $0.01 | |
| 90661 | 0% | 36 | $0.00 | |
| 99000 | 0% | 6,221 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERMAN, SUZANNE (MANAGING PARTNER)